Tentative result for EQAI – Faculty of Medical Technology

Tentative result for EQAI 2017

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TRIAL 01-17-4

Control material NO.	01-17-4-1	01-17-4-2	01-17-4-3	01-17-4-4
Non treponemal test	Non-Reactive	Non-Reactive	Reactive	Reactive
Treponemal test	NS	NS	Reactive	Reactive

TRIAL 01-17-3

Control material NO.	01-17-3-1	01-17-3-2	01-17-3-3	01-17-3-4
Non treponemal test	Reactive	Reactive	Reactive	Reactive
Treponemal test	Reactive	Reactive	Reactive	Reactive

TRIAL 01-17-2

Control material NO.	01-17-2-1	01-17-2-2	01-17-2-3	01-17-2-4
Non treponemal test	Non-Reactive	Non-Reactive	Reactive	Reactive
Treponemal test	Reactive	Reactive	Reactive	Reactive

TRIAL 01-17-1

Control material NO.	01-17-1-1	01-17-1-2	01-17-1-3	01-17-1-4
Non treponemal test	NS	Reactive	Reactive	Reactive
Treponemal test	Reactive	Reactive	Reactive	Reactive

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

TRIAL 02-17-4

Control material NO.	02-17-4-1	02-17-4-2	02-17-4-3	02-17-4-4
HBsAg	NEGATIVE 0.58± 0.11(ECLIA)	NEGATIVE 0.56± 0.11(ECLIA)	POSITIVE 1,519.55± 134.58 (ECLIA)	POSITIVE 2,997.86±236.37 (ECLIA)
antiHBs (all methods) (mIU/ml)	POSITIVE 318.27 ±81.58	POSITIVE 255.13 ± 53.42	NEGATIVE 0.69± 1.02	NEGATIVE 0.60±0.85
antiHBc	POSITIVE	POSITIVE	POSITIVE	POSITIVE
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	POSITIVE	POSITIVE	POSITIVE	POSITIVE

TRIAL 02-17-3

Control material NO.	02-17-3-1	02-17-3-2	02-17-3-3	02-17-3-4
HBsAg	NEGATIVE 0.59± 0.13(ECLIA)	NEGATIVE 0.56± 0.12(ECLIA)	POSITIVE 7,877.87± 599.28 (ECLIA)	POSITIVE 9,764.01±686.08 (ECLIA)
antiHBs (all methods) (mIU/ml)	599.69 ±155.04	POSITIVE 122.74 ± 40.03	NEGATIVE 0.58± 0.96	NEGATIVE 0.44±0.70
antiHBc	NEGATIVE	POSITIVE	POSITIVE	POSITIVE
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	NEGATIVE	POSITIVE	POSITIVE	POSITIVE

TRIAL 02-17-2

Control material NO.	02-17-2-1	02-17-2-2	02-17-2-3	02-17-2-4
HBsAg	NEGATIVE 0.66± 0.40(ECLIA)	POSITIVE 4510.91± 1139.26 (ECLIA)	POSITIVE 1131.69± 483.88 (ECLIA)	POSITIVE 6287.84±1910.80 (ECLIA)
antiHBs (all methods) (mIU/ml)	POSITIVE 490.34 ±78.20	NEGATIVE 1.72 ± 1.40	NEGATIVE 2.89± 2.68	NEGATIVE 1.98±1.90
antiHBc	POSITIVE	POSITIVE	POSITIVE	POSITIVE
HBeAg	NEGATIVE	POSITIVE	POSITIVE	POSITIVE
antiHBe	POSITIVE	NEGATIVE	NEGATIVE	NEGATIVE

TRIAL 02-17-1

Control material NO.	02-17-1-1	02-17-1-2	02-17-1-3	02-17-1-4
HBsAg	POSITIVE 1053± 175.24 (ECLIA)	POSITIVE 847.77± 105.32 (ECLIA)	POSITIVE 879.56± 114.20 (ECLIA)	NEGATIVE 0.23±0.10(ECLIA)
antiHBs (all methods) (mIU/ml)	NEGATIVE 0.5 ±1.49	NEGATIVE 0.50 ± 1.47	NEGATIVE 0.53± 1.47	POSITIVE 161.37±161.85
antiHBc	POSITIVE	POSITIVE	POSITIVE	POSITIVE
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	POSITIVE	POSITIVE	POSITIVE	NEGATIVE

Tentative result for EQAI 2016

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TRIAL 01-16-4

Control material NO.	01-16-4-1	01-16-4-2	01-16-4-3	01-16-4-4
Non treponemal test	Non-Reactive	Non-Reactive	NS	Reactive
Treponemal test	Reactive	Reactive	Reactive	Reactive

TRIAL 01-16-3

Control material NO.	01-16-3-1	01-16-3-2	01-16-3-3	01-16-3-4
Non treponemal test	Reactive	Reactive	Non-Reactive	NS
Treponemal test	Reactive	Reactive	Reactive	Reactive

TRIAL 01-16-2

Control material NO.	01-16-2-1	01-16-2-2	01-16-2-3	01-16-2-4
Non treponemal test	Reactive	Reactive	Reactive	NS
Treponemal test	Reactive	Reactive	Reactive	Reactive

TRIAL 01-16-1

Control material NO.	01-16-1-1	01-16-1-2	01-16-1-3	01-16-1-4
Non treponemal test	Reactive	Reactive	Non-Reactive	Non-Reactive
Treponemal test	Reactive	Reactive	Reactive	Reactive

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

TRIAL 02-16-4

Control material NO.	02-16-4-1	02-16-4-2	02-16-4-3	02-16-4-4
HBsAg	POSITIVE 899.57±108.99 (ECLIA)	POSITIVE 744.45±89316 (ECLIA)	NEGATIVE 0.53±0.13 (ECLIA)	NEGATIVE 0.52± 0.14 (ECLIA)
antiHBs (all methods) (mIU/ml)	NEGATIVE 0.70±1.31	NEGATIVE 0.70±1.49	POSITIVE 542.61±153.62	POSITIVE 322.57±105.91
antiHBc	POSITIVE	NS	POSITIVE	POSITIVE
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	POSITIVE	POSITIVE	POSITIVE	POSITIVE

TRIAL 02-16-3

Control material NO.	02-16-3-1	02-16-3-2	02-16-3-3	02-16-3-4
HBsAg	NEGATIVE 0.51±0.12 (ECLIA)	NEGATIVE 0.49±0.15 (ECLIA)	POSITIVE 690.69±67.44 (ECLIA)	POSITIVE 1,084.51± 120.03 (ECLIA)
antiHBs (all methods) (mIU/ml)	POSITIVE 424.87±89.98	POSITIVE 97.57±18.50	NEGATIVE 0.47±0.86	NEGATIVE 0.58±0.80
antiHBc	NS	NS	NS	POSITIVE
HBeAg	NEGATIVE	NEGATIVE	POSITIVE	NEGATIVE
antiHBe	NEGATIVE	POSITIVE	NEGATIVE	POSITIVE

TRIAL 02-16-2

Control material NO.	02-16-2-1	02-16-2-2	02-16-2-3	02-16-2-4
HBsAg	NS 28.52±4.50 (ECLIA)	NEGATIVE 0.54±0.14 (ECLIA)	POSITIVE 326.01±48.58 (ECLIA)	NEGATIVE 0.55± 0.15 (ECLIA)
antiHBs (all methods) (mIU/ml)	NEGATIVE 1.25±3.68	POSITIVE 149.44±34.26	NEGATIVE 0.76±1.16	POSITIVE 253.74±93.28
antiHBc	NS	NS	NS	NS
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	POSITIVE	POSITIVE	POSITIVE	POSITIVE

TRIAL 02-16-1

Control material NO.	02-16-1-1	02-16-1-2	02-16-1-3	02-16-1-4
HBsAg	NEGATIVE 0.53± 0.18 (ECLIA)	NEGATIVE 0.58± 0.09 (ECLIA)	POSITIVE 167.29± 19.51 (ECLIA)	POSITIVE 624.56± 59.62 (ECLIA)
antiHBs (all methods) (mIU/ml)	POSITIVE 148.06 ±16.53	POSITIVE 88.20 ± 52.11	NEGATIVE 0.88± 1.10	NEGATIVE 0.74±0.85
antiHBc	NS	NS	NS	POSITIVE
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	NS	NS	POSITIVE	POSITIVE

Tentative result for EQAI 2014

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TRIAL 01-14-4

Control material NO.	01-14-4-1	01-14-4-2	01-14-4-3	01-14-4-4
Non treponemal test	Non-Reactive	Reactive	Reactive	Reactive
Treponemal test	Reactive	Reactive	Reactive	Reactive

TRIAL 01-14-3

Control material NO.	01-14-3-1	01-14-3-2	01-14-3-3	01-14-3-4
Non treponemal test	Reactive	Non-Reactive	Reactive	Non-Reactive
Treponemal test	Reactive	Reactive	Reactive	Non-Reactive

TRIAL 01-14-2

Control material NO.	01-14-2-1	01-14-2-2	01-14-2-3	01-14-2-4
Non treponemal test	Reactive	Reactive	Non-Reactive	Non-Reactive
Treponemal test	Reactive	Reactive	Reactive	Non-Reactive

TRIAL 01-14-1

Control material NO.	01-14-1-1	01-14-1-2	01-14-1-3	01-14-1-4
Non treponemal test	Reactive	Reactive	Non-Reactive	Non-Reactive
Treponemal test	Reactive	Reactive	Reactive	Non-Reactive

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

TRIAL 02-14-4

Control material NO.	02-14-4-1	02-14-4-2	02-14-4-3	02-14-4-4
HBsAg (COI)	NEGATIVE 0.55± 0.15 (ECLIA)	NEGATIVE 0.55± 0.16 (ECLIA)	POSITIVE 387.28± 69.9 (ECLIA)	POSITIVE 334.89± 61.17 (ECLIA)
antiHBs (all methods) (mIU/ml)	POSITIVE 336.10 ±92.70	POSITIVE 287.67 ± 64.10	NEGATIVE 1.20± 4.19	NEGATIVE 1.35±6.99
antiHBc	POSITIVE	NS	NS	NS
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	POSITIVE	NS	NEGATIVE	NEGATIVE

TRIAL 02-14-3

Control material NO.	02-14-3-1	02-14-3-2	02-14-3-3	02-14-3-4
HBsAg (COI)	NEGATIVE 0.57± 0.15 (ECLIA)	POSITIVE 259.83± 35.10 (ECLIA)	NEGATIVE 0.57± 0.14 (ECLIA)	POSITIVE 276.76± 29.8 (ECLIA)
antiHBs (all methods) (mIU/ml)	POSITIVE 115.52 ±17.62	NEGATIVE 0.41 ± 0.60	POSITIVE 249.01± 34.56	NEGATIVE 0.50±0.68
antiHBc	NS	POSITIVE	POSITIVE	POSITIVE
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	NEGATIVE	NEGATIVE	NS	NEGATIVE

TRIAL 02-14-2

Control material NO.	02-14-2-1	02-14-2-2	02-14-2-3	02-14-2-4
HBsAg	POSITIVE 5003.75± 343.71 (CMIA)	POSITIVE 809.33± 64.16 (CMIA)	NEGATIVE 0.41± 0.18 (CMIA)	POSITIVE 1606.82± 94.56 (CMIA)
antiHBs (all methods) (mIU/ml)	NEGATIVE 1.42 ±0.5	NEGATIVE 0.24 ± 0.55	POSITIVE 161.5± 66.7	NEGATIVE 0.43±0.55
antiHBc	POSITIVE	POSITIVE	NEGATIVE	POSITIVE
HBeAg	NEGATIVE	POSITIVE	NEGATIVE	NEGATIVE
antiHBe	POSITIVE	NEGATIVE	NEGATIVE	NEGATIVE

TRIAL 02-14-1

Control material NO.	02-14-1-1	02-14-1-2	02-14-1-3	02-14-1-4
HBsAg	NEGATIVE 0.27± 0.12 (CMIA)	NEGATIVE 0.26 ± 0.08 (CMIA)	NS	POSITIVE 699.21± 97.69 (CMIA)
antiHBs (all methods) (mIU/ml)	NEGATIVE 3.59 ± 5.80	NEGATIVE 2.37 ± 0.96	NEGATIVE 0.68± 0.82	NEGATIVE 0.83±1.68
antiHBc	NEGATIVE	NEGATIVE	NS	POSITIVE
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE

Tentative result for EQAI 2013

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TRIAL SE 01-13-4

Control material NO.	SE 01-13-4-1	SE 01-13-4-2	SE 01-13-4-3	SE 01-13-4-4
Non treponemal test	NS	Non-Reactive	Non-Reactive	Reactive
Treponemal test	Reactive	NS	NS	Reactive

TRIAL 01-13-3

Control material NO.	01-13-3-1	01-13-3-2	01-13-3-3	01-13-3-4
Non treponemal test	Reactive	Reactive	Non-Reactive	Non-Reactive
Treponemal test	Reactive	Reactive	Reactive	Reactive

TRIAL 01-13-2

Control material NO.	01-13-2-1	01-13-2-2	01-13-2-3	01-13-2-4
Non treponemal test	Reactive	Reactive	Non-Reactive	Non-Reactive
Treponemal test	Reactive	Reactive	Reactive	Reactive

TRIAL 01-13-1

Control material NO.	01-13-1-1	01-13-1-2	01-13-1-3	01-13-1-4
Non treponemal test	Non-Reactive	Reactive	Non-Reactive	Reactive
Treponemal test	Reactive	Reactive	Reactive	Reactive

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

TRIAL SE 02-13-4

Control material NO.	SE 02-13-4-1	SE 02-13-4-2	SE 02-13-4-3	SE 02-13-4-4
HBsAg (COI)	POSITIVE 457.42± 48.56 (ECLIA)	POSITIVE 350.45 ± 39.65 (ECLIA)	POSITIVE 527.12 ± 55.14 (ECLIA)	NEGATIVE 0.49 ±0.17 (ECLIA)
antiHBs (all methods) (mIU/ml)	NEGATIVE 0.53 ± 0.77	NEGATIVE 0.68 ± 0.48	NEGATIVE 0.40± 0.65	POSITIVE 54.07±26.65
antiHBc	POSITIVE	POSITIVE	POSITIVE	NS
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE

TRIAL 02-13-3

Control material NO.	02-13-3-1	02-13-3-2	02-13-3-3	02-13-3-4
HBsAg (S/CO)	NEGATIVE 0.3± 0.1 (CMIA)	NEGATIVE 0.29 ± 0.09 (CMIA)	NEGATIVE 939.5 ± 196.9 (CMIA)	POSITIVE 821.7 ± 153.8 (CMIA)
antiHBs (all methods) (mIU/ml)	NS 19.39 ± 10.45	NS 12.6 ± 2.8	NEGATIVE 0.7± 0.8	NEGATIVE 0.6±0.8
antiHBc	POSITIVE	NS	POSITIVE	POSITIVE
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE

TRIAL SE 02-13-2

Control material NO.	SE 02-13-2-1	SE 02-13-2-2	SE 02-13-2-3	SE 02-13-2-4
HBsAg (COI)	POSITIVE 726.20± 62.2 (ECLIA)	POSITIVE 572.99 ± 98.58 (ECLIA)	NEGATIVE 0.54 ± 0.16 (ECLIA)	NEGATIVE 0.51 ± 0.14 (ECLIA)
antiHBs (all methods) (mIU/ml)	NEGATIVE 0.56 ± 0.67	NEGATIVE 0.54 ± 0.86	POSITIVE 85.31± 15.90	POSITIVE 87.92±14.88
antiHBc	POSITIVE	POSITIVE	NEGATIVE	NS
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	NS	POSITIVE	NEGATIVE	NEGATIVE

TRIAL 02-13-1

Control material NO.	02-13-1-1	02-13-1-2	02-13-1-3	02-13-1-4
HBsAg	POSITIVE 1631.07± 123.81 (ECLIA)	POSITIVE 1622.9 ± 111.9 (ECLIA)	NEGATIVE 0.53 ± 0.21 (ECLIA)	NEGATIVE 0.52 ± 0.22 (ECLIA)
antiHBs (all methods) (mIU/ml)	NEGATIVE 0.82 ± 1.33	NEGATIVE 0.63 ± 0.86	POSITIVE 242.46± 54.77	POSITIVE 295.95±64.22
antiHBc	POSITIVE	POSITIVE	NS	NS
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	NS	NS	NEGATIVE	NEGATIVE

Tentative result for EQAI 2012

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

Tentative result for EQAI 2011

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

Tentative result for EQAI 2010

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

Tentative result for EQAI 2009

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

Tentative result for EQAI 2008

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

Tentative result for EQAI 2007

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

Tentative result for EQAI 2006

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

Tentative result for EQAI 2005

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

Tentative result for EQAI 2004

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.